Production (Stage)
Envoy Medical, Inc.
COCH
$1.63
-$0.035-2.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 212.00K | 225.00K | 278.00K | 302.00K | 297.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 212.00K | 225.00K | 278.00K | 302.00K | 297.00K |
| Cost of Revenue | 815.00K | 742.00K | 819.00K | 821.00K | 738.00K |
| Gross Profit | -603.00K | -517.00K | -541.00K | -519.00K | -441.00K |
| SG&A Expenses | 8.30M | 8.55M | 10.14M | 9.48M | 9.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.68M | 19.47M | 21.72M | 20.15M | 19.77M |
| Operating Income | -19.47M | -19.24M | -21.44M | -19.85M | -19.47M |
| Income Before Tax | -19.52M | -20.80M | -21.07M | -13.55M | -22.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.52 | -20.80 | -21.07 | -13.55 | -22.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.52M | -20.80M | -21.07M | -13.55M | -22.85M |
| EBIT | -19.47M | -19.24M | -21.44M | -19.85M | -19.47M |
| EBITDA | -19.27M | -19.07M | -21.27M | -19.70M | -19.33M |
| EPS Basic | -1.41 | -1.53 | -1.39 | -0.88 | -1.92 |
| Normalized Basic EPS | -0.64 | -0.70 | -0.69 | -0.70 | -1.40 |
| EPS Diluted | -1.41 | -1.53 | -1.39 | -0.89 | -1.93 |
| Normalized Diluted EPS | -0.64 | -0.70 | -0.69 | -0.69 | -1.38 |
| Average Basic Shares Outstanding | 76.89M | 74.16M | 76.54M | 67.14M | 57.66M |
| Average Diluted Shares Outstanding | 76.89M | 74.16M | 76.54M | 68.14M | 58.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -18.75% | -11.77% | -8.70% | -- | -- |